Synlogic (SYBX) Competitors $1.12 -0.01 (-1.32%) As of 05/22/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SYBX vs. STTK, HOWL, RENB, ICCC, DTIL, FBRX, ARTV, RNTX, BLUE, and PEPGShould you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include Shattuck Labs (STTK), Werewolf Therapeutics (HOWL), Renovaro (RENB), ImmuCell (ICCC), Precision BioSciences (DTIL), Forte Biosciences (FBRX), Artiva Biotherapeutics (ARTV), Rein Therapeutics (RNTX), bluebird bio (BLUE), and PepGen (PEPG). These companies are all part of the "pharmaceutical products" industry. Synlogic vs. Shattuck Labs Werewolf Therapeutics Renovaro ImmuCell Precision BioSciences Forte Biosciences Artiva Biotherapeutics Rein Therapeutics bluebird bio PepGen Synlogic (NASDAQ:SYBX) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation. Do analysts recommend SYBX or STTK? Shattuck Labs has a consensus price target of $7.50, indicating a potential upside of 650.00%. Given Shattuck Labs' stronger consensus rating and higher probable upside, analysts plainly believe Shattuck Labs is more favorable than Synlogic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synlogic 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Shattuck Labs 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.71 Does the media prefer SYBX or STTK? In the previous week, Synlogic's average media sentiment score of 0.00 equaled Shattuck Labs'average media sentiment score. Company Overall Sentiment Synlogic Neutral Shattuck Labs Neutral Do institutionals and insiders hold more shares of SYBX or STTK? 63.4% of Synlogic shares are held by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are held by institutional investors. 3.0% of Synlogic shares are held by company insiders. Comparatively, 10.5% of Shattuck Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, SYBX or STTK? Synlogic has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. Does the MarketBeat Community believe in SYBX or STTK? Synlogic received 292 more outperform votes than Shattuck Labs when rated by MarketBeat users. However, 69.64% of users gave Shattuck Labs an outperform vote while only 69.54% of users gave Synlogic an outperform vote. CompanyUnderperformOutperformSynlogicOutperform Votes33169.54% Underperform Votes14530.46% Shattuck LabsOutperform Votes3969.64% Underperform Votes1730.36% Which has higher earnings and valuation, SYBX or STTK? Synlogic has higher earnings, but lower revenue than Shattuck Labs. Shattuck Labs is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$8K1,628.23-$57.28M-$2.51-0.44Shattuck Labs$4.61M10.40-$87.30M-$1.39-0.72 Is SYBX or STTK more profitable? Synlogic has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. Shattuck Labs' return on equity of -61.92% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -207.84% -114.81% Shattuck Labs -1,156.46%-61.92%-54.49% SummaryShattuck Labs beats Synlogic on 11 of the 17 factors compared between the two stocks. Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYBX vs. The Competition Export to ExcelMetricSynlogicPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.33M$6.47B$5.33B$8.39BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-0.279.0626.7119.71Price / Sales1,628.23251.51386.08120.53Price / CashN/A65.8538.2534.62Price / Book0.246.456.774.50Net Income-$57.28M$143.98M$3.23B$248.22M7 Day Performance3.12%0.38%0.48%-0.78%1 Month Performance-2.82%2.14%9.10%11.53%1 Year Performance-29.51%-0.33%18.56%8.99% Synlogic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYBXSynlogicN/A$1.11-2.3%N/A-30.4%$13.33M$8,000.00-0.2780Upcoming EarningsSTTKShattuck Labs2.5606 of 5 stars$1.05-4.5%$7.50+614.3%-86.9%$50.29M$4.61M-0.69100HOWLWerewolf Therapeutics3.2714 of 5 stars$1.12+0.9%$8.33+644.0%-77.3%$50.26M$1.14M-0.7340RENBRenovaro0.8222 of 5 stars$0.32-1.9%N/A-64.5%$50.12MN/A-0.3420News CoverageGap UpICCCImmuCell0.1875 of 5 stars$5.48+4.0%N/A+31.2%$49.52M$26.49M-10.9670Gap UpDTILPrecision BioSciences3.4318 of 5 stars$4.69-0.4%$47.00+902.1%-64.5%$49.48M$68.70M78.18200Earnings ReportAnalyst ForecastFBRXForte Biosciences2.6153 of 5 stars$7.50-4.5%$32.50+333.3%+31,233.3%$49.37MN/A-0.465News CoverageEarnings ReportAnalyst DowngradeARTVArtiva Biotherapeutics1.6879 of 5 stars$2.02-0.5%$19.40+860.4%N/A$49.21M$251,000.000.0081RNTXRein TherapeuticsN/A$2.15-2.7%N/AN/A$48.96MN/A-0.699Earnings ReportBLUEbluebird bio2.7122 of 5 stars$4.98+0.2%$44.60+795.6%-74.6%$48.76M$83.81M-0.13520PEPGPepGen2.9125 of 5 stars$1.49-3.2%$9.67+548.8%-89.5%$48.75MN/A-0.5030 Related Companies and Tools Related Companies Shattuck Labs Competitors Werewolf Therapeutics Competitors Renovaro Competitors ImmuCell Competitors Precision BioSciences Competitors Forte Biosciences Competitors Artiva Biotherapeutics Competitors Rein Therapeutics Competitors bluebird bio Competitors PepGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SYBX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synlogic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYBX Stock Free SYBX Stock Alerts